ABSTRACT
Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation- associated ICH.
- Copyright © 2010 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage: A prognostic marker
- Head injury in the elderly - an overview for the physician
- Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
- Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation
- What to do after the bleed: resuming anticoagulation after major bleeding
- Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study